Why the study?
Observational data suggest asymptomatic severe aortic stenosis is associated with higher cardiovascular events than previously appreciated, yet most patients are still managed with watchful waiting rather than early intervention.
Does early aortic valve replacement reduce cardiovascular events in patients with asymptomatic severe aortic stenosis compared to a watchful-waiting approach?
Does early aortic valve replacement reduce cardiovascular events in patients with asymptomatic severe aortic stenosis compared to a watchful-waiting approach?
This review highlights the emerging evidence supporting early aortic valve replacement in selected high-risk patients with asymptomatic severe aortic stenosis to prevent future cardiovascular events.
Answers are grounded in this paper and cite their sources.
Should not yet alter watchful waiting in asymptomatic severe AS; leaves open early AVR benefit in high-risk subgroups.
Severe aortic stenosis (sAS) is a relentless disease, which carries significant morbidity and mortality. Definitive treatment of sAS in the form of aortic valve replacement (AVR) mostly revolves around the presence of symptoms. Last decade has witnessed a surge in observational data suggesting asymptomatic sAS associated with higher cardiovascular events than what was previously appreciated. While society guidelines endorse early AVR in a selected subgroup of asymptomatic sAS patients, the majority are still managed with traditional “watchful-waiting” approach. This article reviews the available literature on the natural history of asymptomatic sAS, associated risk modifiers, and identify patients who are at high-risk for future clinical events to offer them preemptive valve placement therapy.
No takes yet. Share an insight, caveat, or question.
Anoop Agrawal (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: